Humalog and Swelling of fingers for Men aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Swelling of fingers is found for men aged 50-59 who take Humalog (insulin lispro recombinant). This study is created by eHealthMe based on reports of 6,294 men aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Humalog when people have Swelling of fingers
Top conditions
Top co-used drugs
Top other side effects

On Jan, 19, 2026

6,294 men aged 50-59 reported to have side effects when taking Humalog.
Among them, 45 people (0.71%) have Swelling of fingers

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,126 Humalog users. Check the latest studies of Humalog.

What is Swelling of fingers?

Swelling of fingers is found to be associated with 3,149 drugs and 2,940 conditions by eHealthMe. Check the latest studies of Swelling of fingers.

Number of reports submitted per year:

Could Humalog cause Swelling of fingers in men aged 50-59?

Severity of Swelling of fingers

n/a

How people recovered from Swelling of fingers

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Pain: 9 people, 20.00%
Blood Phosphorus Increased: 7 people, 15.56%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 7 people, 15.56%
Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 11.11%
Muscle Spasms (muscle contraction): 4 people, 8.89%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 6.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 4.44%
Constipation: 2 people, 4.44%
Gastric Ulcer (stomach ulcer): 2 people, 4.44%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.44%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Joint Pain: 33 people, 73.33%
Joint Range Of Motion Decreased (disease of joint movement): 28 people, 62.22%
Rheumatoid Nodule (a local swelling or tissue lump with rheumatoid disease): 21 people, 46.67%
Nodule (a growth of abnormal tissue): 21 people, 46.67%
Deformity (disfigurement): 21 people, 46.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 21 people, 46.67%
Therapeutic Response Decreased (less preventive response): 21 people, 46.67%
Tenderness (pain or discomfort when an affected area is touched): 21 people, 46.67%
High Blood Pressure: 21 people, 46.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 21 people, 46.67%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and have Swelling of fingers?

- Check whether Swelling of fingers is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Humalog and Swelling of fingers

How the study uses the data?

The study is based on (applicable) gender, age, insulin lispro recombinant (the active ingredients of Humalog) and Humalog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.